Basit öğe kaydını göster

dc.contributor.authorSakallı Kanı, Ayşe
dc.contributor.authorÖzercan, Ahmet
dc.contributor.authorKanı, Haluk Tarık
dc.contributor.authorEren, Fatih
dc.contributor.authorSayar, Kemal
dc.contributor.authorYılmaz, Yusuf
dc.date.accessioned2023-10-27T06:41:54Z
dc.date.available2023-10-27T06:41:54Z
dc.date.issued2023en_US
dc.identifier.citationKani, A. S., Ozercan, A., Kani, H. T., Eren, F., Sayar, K., & Yilmaz, Y. (2023). Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis. Hepatology forum, 4(3), 123–128. https://doi.org/10.14744/hf.2023.2023.0034en_US
dc.identifier.issn2757-7392
dc.identifier.issn1307-5888
dc.identifier.issn2757-7392
dc.identifier.urihttps://doi.org/10.14744/hf.2023.2023.0034
dc.identifier.urihttps://hdl.handle.net/11436/8583
dc.description.abstractBackground and Aim: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In addition, we aim to establish a correlation between these variables and the severity of the disease and fibrosis. Materials and Methods: Patients who were following up with biopsy-proven metabolic dysfunction associated steatotic liver disease (MASLD) were included in the study. Histologically severe disease is characterized by a Steatosis, Activity, and Fibrosis activity score of ≥3 or the presence of advanced fibrosis (≥F3). Participants who met the inclusion criteria were given the Morningness and Evening Questionnaire (MEQ), the Pittsburgh Sleep Quality Index, and the Night Eating Questionnaire to complete. Results: A total of 93 patients were included in this study. According to the MEQ, 48 patients were morning type (51.6%), and 42 (45.2%) were neither type. Sleep quality was determined to be inferior in the non-morningness group (p=0.002). A significantly higher proportion of patients with nocturnal eating syndrome had a non-morningness chronotype preference (n=22, 23.7%), compared to those with a morningness chronotype (n=9, 9.7%) (p=0.001). In the multivariate analysis, both age and poor sleep quality had significant impacts on advanced fibrosis, with odds ratios of 1.11 and 3.81, respectively. Conclusion: Despite the non-morningness chronotype demonstrating poorer sleep quality and a higher prevalence of night-eating behavior, our findings revealed no statistically significant differences in terms of sleep quality, nocturnal eating habits, or chronotype preferences among patients with varying degrees of MASLD severity. On the other hand, advanced fibrosis was significantly impacted by poor sleep qualityen_US
dc.language.isoengen_US
dc.publisherKare Publishingen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronotypeen_US
dc.subjectNight eating behavioren_US
dc.subjectSleep qualityen_US
dc.subjectSteatotic liver diseaseen_US
dc.titleChronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosisen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorYılmaz, Yusuf
dc.identifier.doi10.14744/hf.2023.2023.0034en_US
dc.identifier.volume4en_US
dc.identifier.issue3en_US
dc.identifier.startpage123en_US
dc.identifier.endpage128en_US
dc.relation.journalHepatology Forumen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster